Myeloproliferative disease and myelodysplastic syndrome induced by transplantation of bone marrow cells expressing mutant p53

Leukemia

Volumn 11, Issue 10, 1997, Pages 1641-1649

  Shounan, Y ^a,b   MacKenzie, K ^b,d   Dolnikov, A ^b   Miller, M ^a   Symonds, G ^a,b,c  

^a JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c ST VINCENT S HOSPITAL   (Australia)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

BM reconstitution; Hematopoietic cell transformation; Hematopoietic disorders; Mutant p53; Retrovirally mediated gene transfer

Indexed keywords

MUTANT PROTEIN; PROTEIN P53;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CELL TRANSFORMATION; FEMALE; GENE TRANSFER; HEMATOPOIETIC CELL; MOUSE; MYELODYSPLASTIC SYNDROME; MYELOPROLIFERATIVE DISORDER; NONHUMAN; PRIORITY JOURNAL;

EID: 0030670482     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2400782     Document Type: Article

References (9)

1. Furihata M, Sonobe H, Ohtsuki Y. The aberrant p53 protein (review). Int J Oncol 1995; 6: 1209-1226.
2. Levine AJ. The tumor suppressor genes. Annu Rev Biochem 1993; 62: 623-651.
3. Imamura J, Miyoshi I, Koeffler HP. p53 in hematologic malignancies. Blood 1994; 84: 2412-2421.
4. Levine JA, Momand J, Finlay CA. The p53 tumor suppressor gene. Nature 1991; 351: 453-456.
5. Lavigueur A, Maltby V, Mock D, Rossant J, Pawson T, Bernstein A. High incidence of lung, bone, and lymphoid tumors in transgenic mice overexpressing mutant alleles of the p53 oncogene. Mol Cell Biol 1989; 9: 3982-3991.
6. Hinds P, Finlay C, Levine AJ. Mutations are required to active the p53 gene for cooperation with the ras oncogene and transformation. J Virol 1989; 63: 739-746.
7. Bi S, Barton CM, Lemoine NR, Cross NCP, Goldman JM. Retroviral transduction of Philadelphia-positive chronic myeloid leukemia cells with a human mutant p53 cDNA and its effect on in vitro proliferation. Exp Hematol 1994; 22: 95-99.
8. Milner J, Medcalf EA, Cook AC. Tumor suppressor p53: analysis of wild-type and mutant p53 complexes. Mol Cell Biol 1991; 11: 12-19.
9. Kern SE, Pietenpol JA, Thiagalingam S, Seymour A, Kinzler KW, Vogelstein B. Oncogenic forms of p53 inhibit p53-regulated gene expression. Science 1992; 256: 827-830.